By analyzing existing technical indicators between Tabula Rasa and GoodRx, you can compare the effects of market volatilities on both companies' prices and check if they can diversify away market risk if combined in one of your portfolios. You can also utilize pair trading strategies for matching a long position in GoodRx with a short position in Tabula Rasa. Check out our
pair correlation module for more information.
Let's begin by analyzing the assets.
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Tabula Rasa has an asset utilization ratio of 523.11 percent. This suggests that the company is making $5.23 for each dollar of assets. An increasing asset utilization means that Tabula Rasa Healthcare is more efficient with each dollar of assets it utilizes for everyday operations.
How important is Tabula Rasa's Liquidity
Tabula Rasa
financial leverage refers to using borrowed capital as a funding source to finance Tabula Rasa HealthCare ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Tabula Rasa financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Tabula Rasa's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Tabula Rasa's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between Tabula Rasa's total debt and its cash.
What is the case for Tabula Rasa Investors
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Revenue Breakdown
Let me now go over Tabula Rasa revenue. Based on the latest financial disclosure, Tabula Rasa Healthcare reported 306.55
M of revenue. This is 95.98% lower than that of the Healthcare sector and significantly higher than that of the
Health Information Services industry. The revenue for all United States stocks is 96.75% higher than that of the entity. As for GoodRx Holdings we see revenue of 631.06
M, which is much higher than that of the Health Information Services
| Tabula | 306.55 Million |
| Sector | 0.0 |
| GoodRx | 631.06 Million |
Our perspective of the current Tabula Rasa rise
Mean deviation is down to 4.22. It may suggest a possible volatility slip.
As of the 13th of December 2021, Tabula Rasa has the
coefficient of variation of
(644.34), and Risk Adjusted Performance of
(0.13). In relation to
fundamental indicators, the
technical analysis model makes it possible for you to check existing technical drivers of Tabula Rasa Healthcare, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We have analyze and collected data for nineteen
technical drivers for Tabula Rasa Healthcare, which can be compared to its competition. Please validate
Tabula Rasa Healthcare treynor ratio, and the
relationship between the
standard deviation and
downside variance to decide if Tabula Rasa is priced more or less accurately, providing market reflects its prevalent price of 12.46 per share. Given that Tabula Rasa Healthcare has
jensen alpha of
(1.26), we advise you to double-check Tabula Rasa Healthcare's current market performance to make sure the company can sustain itself at a future point.
Our Final Takeaway
Whereas some other firms under the health information services industry are still a bit expensive, Tabula Rasa may offer a potential longer-term growth to investors. While some investors may not share our view we believe that the current risk-reward utility is not appealing enough to do any trading. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Tabula Rasa.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Gabriel Shpitalnik is a Member of Macroaxis Editorial Board. Gabriel is a young entrepreneur and writes predominantly on the business, technology, and finance sector. He likes to analyze different equity instruments across a wide range of industries focusing primarily on consumer products and evolving technologies.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Gabriel Shpitalnik do not own shares of Tabula Rasa HealthCare. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
[email protected]